Raw materials play a critical role in cell therapy manufacturing. Choosing suboptimal materials at any stage of development ...
Multiply Labs' goal is to enable scalable, high-throughput manufacturing while maintaining rigorous quality and regulatory standards.
Lumacyte CEO on how real-time insight is driving down manufacturing failures and opening doors for more patients.
Universal gene‑edited CAR‑T therapies turn donor T cells into off‑the‑shelf cancer treatments, cutting delays and costs while ...
The cell and gene therapy sector has never lacked attention, but all too often, the narrative swings from one extreme to ...
To evaluate the potential for applying GMP-ready robotic systems to commercial-scale cell therapy manufacturing.
The global cell and gene therapy market is experiencing explosive growth. Key growth factors include rising chronic/genetic disease prevalence, advancements in gene editing (CRISPR) and viral vectors, ...
Although rheumatologists consider chimeric antigen receptor T-cell therapy “potentially transformative,” nearly 70% remain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results